โทรศัพท์: 095-718-3535, 083-905-8333   

FB: hairderma   LINE ID: @hairderma   

ที่ตั้ง: ชั้น 3 ร้านสวัสดิการกองทัพเรือ (นันทอุทยาน), 2/9 ถนนอิสรภาพ บางกอกน้อย กทม 10700 คลิกเพื่อดูแผนที่   

แพทย์หญิง ชญาณี ลิขิตวัฒนานุรักษ์

Email Address

hairderma@yahoo.com

EDUCATION

Diploma of the Thai Board of Dermatology, Siriraj hospital, Mahidol University

2017 – 2021

Dermatology residency training, Department of Dermatology, Siriraj Hospital, Mahiol University

M.D. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

WORK EXPERIENCE

2015 – 2016

Dermatology research fellow, Department of dermatology, Faculty of Medicine, Siriraj hospital

  • Co-authored clinical tracer plus for androgenetic alopecia in Siriraj hospital
  • Journal presentation
    • “Cutaneous toxicities of epidermal growth factor receptor inhibitors: A prospective study in 60 Asian patients” at 42nd Dermatology Society of Thailand Annual Meeting
    • “Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian Population” at 41st Dermatology Society of Thailand Annual Meeting
  • “A pilot study - Comparison of two techniques of hair follicular stem cell harvesting for hair transplantation, the standard follicular unit extraction technique versus adjacent follicular harvesting technique” at Asian Dermatological Congress, Mumbai, India
2014 - 2015

First year internship, Panyananthaphikkhu Chonlapratarn Medical Center (PCMC), Nonthaburi, Thailand

PROFESSIONAL MEMBERSHIP

2015 - present

General member, Dermatological Society of Thailand

2014 - present

General member, Medical Council of Thailand

ORIGINAL PUBLICATIONS

Kulthanan K, Tuchinda P, Chularojanamontri L, Likitwattananurak C, Ungaksornpairote C. Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population. J Dermatol Treat. 2016; 7:1-6.

Chularojanamontri L, Tuchinda P, Likitwattananurak C, Pongparit K, Rujitharanawong C, Ithimakin S, Kulthanan K. Cutaneous toxicities of epidermal growth factor receptor inhibitors: A prospective study in 60 Asian patients. Asian Pac J Allergy Immunol. 2019; 37(1):12-18.

Kulthanan K, Tuchinda P, Likitwattananurak C, Weerasubpong P, Chularojanamontri L. Does omalizumab modify a course of recalcitrant chronic spontaneous urticaria?: A retrospective study in Asian patients. J Dermatol. 2018; 45(1):17-23.

Likitwattananurak, C., Leecharoen, W., & Boonchai, W. (2020). Management of Cyclosporine-worsening acral erythema. Thai Journal of Dermatology, 36(1), 15-19.

Chularojanamontri L., Silpa-archa N., Chaweekulrat P., Likitwattananurak C., Weerasubpong P., Junsuwan N., Charoenpipatsin N., Wongpraparut C. A randomised controlled trial of the efficacy and safety of 0.25% desoximetasone cream (Topoxy) compared with 0.25% desoximetasone cream (Topicorte) for the treatment of scalp psoriasis. Siriraj Medical Journal. 2020. 72(5): 371-379.

RESEARCHES

A Comparative efficacy of topical Finasteride solution and 5% Minoxidil solution in androgenetic alopecia treatment

An efficacy of oral iron supplement therapy in female-patterned hair loss woman accompanied with different low serum ferritin level: A pilot study

Proteome analysis to detect antigen-antibodies reactions in epidermal and dermal tissues in patients with psoriasis

;